Nanyang Liu

1.2k total citations
32 papers, 778 citations indexed

About

Nanyang Liu is a scholar working on Molecular Biology, Infectious Diseases and Physiology. According to data from OpenAlex, Nanyang Liu has authored 32 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Infectious Diseases and 8 papers in Physiology. Recurrent topics in Nanyang Liu's work include COVID-19 Clinical Research Studies (8 papers), Alzheimer's disease research and treatments (5 papers) and Computational Drug Discovery Methods (4 papers). Nanyang Liu is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), Alzheimer's disease research and treatments (5 papers) and Computational Drug Discovery Methods (4 papers). Nanyang Liu collaborates with scholars based in China, Israel and United Kingdom. Nanyang Liu's co-authors include Hao Li, Jiahui Sun, Tingting Zhang, Lina Ma, Xiyuan Wang, Hui Pei, Hao Li, Ming Zhao, Yu Cao and Yun Wei and has published in prestigious journals such as Medicine, Frontiers in Pharmacology and Journal of Alzheimer s Disease.

In The Last Decade

Nanyang Liu

31 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nanyang Liu China 14 205 201 153 118 104 32 778
Sofia Viana Portugal 19 426 2.1× 156 0.8× 305 2.0× 42 0.4× 104 1.0× 50 1.1k
Maryam Mehrpooya Iran 16 130 0.6× 45 0.2× 94 0.6× 41 0.3× 42 0.4× 70 677
Mayur Parmar United States 18 229 1.1× 68 0.3× 225 1.5× 20 0.2× 100 1.0× 60 795
Baitao Ma China 12 424 2.1× 236 1.2× 60 0.4× 37 0.3× 174 1.7× 22 1.1k
Nicola Wilck Germany 19 634 3.1× 74 0.4× 251 1.6× 63 0.5× 30 0.3× 43 1.2k
Mohit Kumar India 13 131 0.6× 58 0.3× 267 1.7× 34 0.3× 149 1.4× 39 820
Shujing Zhang China 17 288 1.4× 206 1.0× 74 0.5× 42 0.4× 103 1.0× 77 977
Guang Chen China 17 252 1.2× 149 0.7× 70 0.5× 28 0.2× 94 0.9× 36 955
Angela Koverech Italy 15 206 1.0× 52 0.3× 227 1.5× 72 0.6× 38 0.4× 29 944
Sudeep Shrestha Nepal 17 186 0.9× 23 0.1× 160 1.0× 62 0.5× 75 0.7× 52 910

Countries citing papers authored by Nanyang Liu

Since Specialization
Citations

This map shows the geographic impact of Nanyang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanyang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanyang Liu more than expected).

Fields of papers citing papers by Nanyang Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanyang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanyang Liu. The network helps show where Nanyang Liu may publish in the future.

Co-authorship network of co-authors of Nanyang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Nanyang Liu. A scholar is included among the top collaborators of Nanyang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanyang Liu. Nanyang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Guo, Zhijiang, Nanyang Liu, Ye Chen, et al.. (2024). Mitochondrial Stress as a Central Player in the Pathogenesis of Hypoxia-Related Myocardial Dysfunction: New Insights. International Journal of Medical Sciences. 21(13). 2502–2509. 9 indexed citations
3.
Liu, Nanyang, et al.. (2024). Dual-specificity phosphatase 1 interacts with prohibitin 2 to improve mitochondrial quality control against type-3 cardiorenal syndrome. International Journal of Medical Sciences. 21(3). 547–561. 7 indexed citations
4.
Zhuang, Haowen, Xiaocui Yang, Zhijiang Guo, et al.. (2024). Exploring the Mechanism of Ferroptosis Induction by Sappanone A in Cancer: Insights into the Mitochondrial Dysfunction Mediated by NRF2/xCT/GPX4 Axis. International Journal of Biological Sciences. 20(13). 5145–5161. 44 indexed citations
5.
Liu, Nanyang, et al.. (2023). Nanoparticles loaded with natural medicines for the treatment of Alzheimer’s disease. Frontiers in Neuroscience. 17. 1112435–1112435. 9 indexed citations
6.
Li, Jiajun, et al.. (2023). Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis. Frontiers in Public Health. 11. 1170156–1170156. 19 indexed citations
7.
Liu, Nanyang, Xuefan Jiang, & Hao Li. (2023). The viral hypothesis in Alzheimer’s disease: SARS-CoV-2 on the cusp. Frontiers in Aging Neuroscience. 15. 1129640–1129640. 15 indexed citations
8.
Zhang, Tingting, et al.. (2022). Fecal Microbiota Transplantation and Health Outcomes: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials. Frontiers in Cellular and Infection Microbiology. 12. 899845–899845. 10 indexed citations
9.
Xiao, Peng, et al.. (2022). Efficacy and Safety of Chinese Medicine Lianhua Qingwen for Treating COVID-19: An Updated meta-Analysis. Frontiers in Pharmacology. 13. 888820–888820. 4 indexed citations
10.
Liu, Nanyang, et al.. (2022). Inflammatory bowel disease and risk of dementia: An updated meta-analysis. Frontiers in Aging Neuroscience. 14. 962681–962681. 13 indexed citations
11.
Wei, Lanlan, et al.. (2022). Interferon-induced transmembrane protein 3 gene polymorphisms are associated with COVID-19 susceptibility and severity: A meta-analysis. Journal of Infection. 84(6). 825–833. 18 indexed citations
12.
Zhang, Tingting, Nanyang Liu, Wei Wei, Zhen Zhang, & Hao Li. (2021). Integrated Analysis of Weighted Gene Coexpression Network Analysis Identifying Six Genes as Novel Biomarkers for Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity. 2021(1). 9918498–9918498. 25 indexed citations
13.
Liu, Nanyang, Tingting Zhang, Lina Ma, et al.. (2021). Vitamin D Receptor Gene Polymorphisms and Risk of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. Advances in Nutrition. 12(6). 2255–2264. 19 indexed citations
14.
Liu, Nanyang, Jiahui Sun, Xiyuan Wang, et al.. (2021). Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis. International Journal of Infectious Diseases. 104. 58–64. 129 indexed citations
15.
Liu, Nanyang, Tingting Zhang, Jiahui Sun, et al.. (2021). An Overview of Systematic Reviews of Chinese Herbal Medicine for Alzheimer’s Disease. Frontiers in Pharmacology. 12. 761661–761661. 13 indexed citations
16.
17.
Zhang, Tingting, Linlin Pan, Yu Cao, et al.. (2020). <p>Identifying the Mechanisms and Molecular Targets of Yizhiqingxin Formula on Alzheimer’s Disease: Coupling Network Pharmacology with GEO Database</p>. Pharmacogenomics and Personalized Medicine. Volume 13. 487–502. 6 indexed citations
18.
Zhang, Tingting, et al.. (2020). Different Doses of Pharmacological Treatments for Mild to Moderate Alzheimer’s Disease: A Bayesian Network Meta-Analysis. Frontiers in Pharmacology. 11. 778–778. 24 indexed citations
19.
Zhang, Huiqin, Yu Cao, Hui Pei, et al.. (2020). Shenmayizhi Formula Combined with Ginkgo Extract Tablets for the Treatment of Vascular Dementia: A Randomized, Double‐Blind, Controlled Trial. Evidence-based Complementary and Alternative Medicine. 2020(1). 8312347–8312347. 12 indexed citations
20.
Liu, Nanyang, Yun Wei, Hui Pei, et al.. (2019). Efficacy and safety of Shenmayizhi decoction as an adjuvant treatment for vascular dementia. Medicine. 98(50). e18326–e18326. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sofia Viana Breakdown of academic impact, for papers by Maryam Mehrpooya Breakdown of academic impact, for papers by Mayur Parmar Breakdown of academic impact, for papers by Baitao Ma Breakdown of academic impact, for papers by Nicola Wilck Breakdown of academic impact, for papers by Mohit Kumar Breakdown of academic impact, for papers by Shujing Zhang Breakdown of academic impact, for papers by Guang Chen Breakdown of academic impact, for papers by Angela Koverech Breakdown of academic impact, for papers by Sudeep Shrestha
Rankless by CCL
2026